SB526 SFA Takubo, Tarr, Weld #1 3-13
Long 7952
Senator Takubo, Tarr, and Weld moved to amend the bill by striking out everything after the enacting clause and inserting in lieu thereof the following:
This act shall be known and may be cited as the Pharmacist Prescribing Authority Act.
The purpose of this act is to authorize pharmacists to practice the full extent of their education and training to prescribe low-risk medications to patients.
(a) The scope of the practice of pharmacy includes all of §30-5-1 et seq. of this code, as well as the prescribing of drugs or devices, excluding controlled substances, that are prescribed in accordance with the product’s federal Food and Drug Administration-approved labeling, provided that all of the following requirements have been met:
(1) The pharmacist administers a test of a self-limiting condition that is used to guide diagnosis or clinical decision-making and that has been waived under the federal Clinical Laboratory Improvement Amendments of 1988;
(2) That test is positive for a self-limiting condition;
(3) The pharmacist completes a comprehensive medication and medical history review prior to prescribing a permissible drug or device; and
(4) The pharmacist notifies the patient’s primary care provider of record of the positive test and any permissible drug and/or device prescribed within seventy-two hours;
(5) Further, the same condition shall not be subsequently treated by a pharmacist within ninety days of a prescription issued pursuant to this act.
(b) A pharmacist may refill an expired prescription for an epinephrine injection device without meeting the requirements of subsection (a) of this section provided that the pharmacist notifies the patient’s primary care provider of record within seventy-two hours of that prescription.
Adopted
Rejected